3652 results for «320»
3652 results
Clinical cases - Coronary interventions - Session 2
06 Oct 2022 – From AICT-AsiaPCR 2022
Abstracts - Coronary interventions - Session 2
06 Oct 2022 – From AICT-AsiaPCR 2022
Abstracts - Coronary interventions - Session 3
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 4
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Structural interventions - Session 6
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 5
07 Oct 2022 – From AICT-AsiaPCR 2022
Abstracts - Coronary interventions - Session 4
07 Oct 2022 – From AICT-AsiaPCR 2022
Outcome of women in different cardiovascular interventions
06 Oct 2022 – From AICT-AsiaPCR 2022
Data from benchmark registry demonstrate improved TAVR efficiency with preserved patient safety
17 May 2023
EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
EuroPCR 2023 – The interventional cardiovascular community is gathering in Paris to learn, share, and shape the future of patient care worldwide
15 May 2023
EuroPCR, the annual world-leading Course in interventional cardiovascular medicine, has been taking place for over 30 years. It is tailored for all those dedicated to the sharing of knowledge and skills, and improvement of patient care worldwide: interventional cardiologists, cardiac surgeons, imaging specialists, radiologists, nurses, allied...
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes: The multicenter, randomized, blinded, IVUS-ACS Trial
09 Apr 2024
Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)
Author
Author
